ObjectiveTo determine the diagnostic and therapeutic value of contrast‐enhanced ultrasound‐guided endoscopic retrograde appendicitis treatment (ERAT) in patients with uncomplicated appendicitis.MethodsA retrospective analysis was performed on clinical and ultrasound data collected from 105 pediatric patients with uncomplicated appendicitis between January 2020 and December 2023. The ultrasound findings before and after treatment, as well as postoperative follow‐up and recurrence rates, were summarized and analyzed.ResultsSuccessful intubation was achieved in 96 patients (91.4%). The conventional ultrasound appendix visualization rate was 39.6% (38/105), while the appendix visualization rate after contrast‐enhanced ultrasound‐guidance was 75% (72/105). Contrast‐enhanced ultrasound revealed various appendiceal morphologic changes in 89 patients, such as twisting, tortuosity, stiffness, rough inner wall, dilated diameter, and narrowing of the lumen. Additionally, local filling defects, which indicated the presence of fecal stones or debris deposition, were noted in 68 patients. No leakage of the contrast agent occurred. Post‐treatment evaluation showed improvement in appendiceal diameter, lumen, and filling defects (P < .01). The follow‐up rate was 82 of 89 patients (92.1%), all of whom recovered well without a recurrence. The recurrence rate was 7.9% (7/89). Among the patients with recurrences, five patients resolved after medical treatment and two patients recovered after surgical treatment.ConclusionContrast‐enhanced ultrasound‐guided ERAT for uncomplicated appendicitis is safe and effective. Specifically, the appendix is increased, which facilitates an evaluation of therapeutic effectiveness. ERAT serves as a valuable supplementary modality to determine the need for surgical treatment of acute appendicitis, which is of significant clinical value.